REPETITIVE INTRACRANIAL INJECTION OF NATURAL KILLER CELLS ENGINEERED WITH A HER2-TARGETED CHIMERIC ANTIGEN RECEPTOR ALONE AND IN COMBINATION WITH SYSTEMIC ANTI-PD-1 CHECKPOINT INHIBITION IN PATIENTS WITH RECURRENT GLIOBLASTOMA. - Burger, M.; Ehrend, E.; Straßheimer, F.; Cakmak, P.; Krenzlin, H.; Elleringmann, P.; Zeiner, P.; Herkt, S.C.; Poschke, I.; Macas, J.; Weber, K.; Schupp, J.; et al. (Cytotherapy (Elsevier Inc.), 2026)